Search - Archive ouverte HAL Access content directly

Filter your results

75 Results
Structure: Internal structure identifier : 476502

The European Hematology Association Roadmap for European Hematology Research: a consensus document

Jagadeesh Bayry , A. Engert , T. de Wit , T. Green , F. de Haas et al.
Haematologica, 2016, 101 (2), pp.115-208. ⟨10.3324/haematol.2015.136739⟩
Journal articles inserm-02455473v1

Molecular monitoring of patients with ETV6-PDGFRB rearrangement: Implications for therapeutic adaptation.

Audrey Bidet , Claudine Chollet , Martine Gardembas , Franck E Nicolini , Philippe Genet et al.
British Journal of Haematology, 2018, 182 (1), pp.148-152. ⟨10.1111/bjh.14748⟩
Journal articles hal-01557370v1

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma

Lars Jordheim , V. Ribrag , H. Ghesquières , S. Pallardy , R. Delarue et al.
Haematologica, 2015, 100 (5), pp.e204-e206. ⟨10.3324/haematol.2014.120113⟩
Journal articles hal-02332328v1

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Delphine Rea , Franck Nicolini , Michel Tulliez , François Guilhot , Joëlle Guilhot et al.
Blood, 2017, 129 (7), pp.846-854. ⟨10.1182/blood-2016-09-742205⟩
Journal articles hal-02050833v1
Image document

Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

Gabriel Etienne , Stéphanie Dulucq , Françoise Huguet , Anna Schmitt , Axelle Lascaux et al.
Cancer Medicine, 2019, 8 (11), pp.5173-5182. ⟨10.1002/cam4.2410⟩
Journal articles hal-02395152v1
Image document

⁹⁰Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study

Patrice Chevallier , Thomas Eugène , Nelly Robillard , Françoise Isnard , Franck Nicolini et al.
The Lancet, 2015, 2 (3), pp.e108-17. ⟨10.1016/S2352-3026(15)00020-4⟩
Journal articles inserm-02913620v1
Image document

Standardization of 18 F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma

Elena Zamagni , Cristina Nanni , Luca Dozza , Thomas Carlier , Clément Bailly et al.
Journal of Clinical Oncology, 2020, 38, Online ahead of print. ⟨10.1200/JCO.20.00386⟩
Journal articles inserm-03007037v1

Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?

Pierre Sujobert , Gilles Salles , Emmanuel Bachy
Hematology/Oncology Clinics of North America, 2016, 30 (6), pp.1163-1177. ⟨10.1016/j.hoc.2016.07.001⟩
Journal articles hal-01800003v1
Image document

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

C Faucher , A Le Corroller Soriano , B Esterni , N. Vey , A Stoppa et al.
Bone Marrow Transplantation, 2012, 47 (4), pp.549-555. ⟨10.1038/bmt.2011.126⟩
Journal articles inserm-02294378v1
Image document

Further Characterization of Clinical and Laboratory Features in VEXAS Syndrome: Large-scale Analysis of a Multicentre Case Series of 116 French Patients

S. Georgin-Lavialle , B. Terrier , A.F. Guedon , M. Heiblig , T. Comont et al.
British Journal of Dermatology, 2022, 186 (3), pp.564-574. ⟨10.1111/bjd.20805⟩
Journal articles hal-03707355v1
Image document

Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation

Rathana Kim , Nicolas Boissel , Aurore Touzart , Thibaut Leguay , Florian Thonier et al.
Leukemia, 2020, Epub ahead of print. ⟨10.1038/s41375-019-0685-4⟩
Journal articles inserm-02551756v1
Image document

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.

Mira Tout , Olivier Casasnovas , Michel Meignan , Thierry Lamy , Franck Morschhauser et al.
Blood, 2017, 129 (19), pp.2616-2623. ⟨10.1182/blood-2016-10-744292⟩
Journal articles hal-01547802v1

Delta Hemolysin and Phenol-Soluble Modulins, but Not Alpha Hemolysin or Panton-Valentine Leukocidin, Induce Mast Cell Activation

Elisabeth Hodille , Charlotte Cuerq , Cédric Badiou , Françoise Bienvenu , Jean-Paul Steghens et al.
Frontiers in Cellular and Infection Microbiology, 2016, 6, pp.180. ⟨10.3389/fcimb.2016.00180⟩
Journal articles hal-01910928v1
Image document

Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient

M. Heiblig , V. Bozzoli , J. Saison , X. Thomas , D. de Croze et al.
Mycoses, 2015, 58 (5), pp.308--312. ⟨10.1111/myc.12305⟩
Journal articles pasteur-01405220v1

Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia

Julien Saison , Françoise Berger , Fanny Lebosse , Regis Audoual , Xavier Thomas et al.
The American Journal of Case Reports, 2014, 15, pp.13-17. ⟨10.12659/AJCR.889867⟩
Journal articles hal-01911353v1

Obinutuzumab in hematologic malignancies: Lessons learned to date

Tim Illidge , Christian Klein , Laurie Sehn , Andrew Davies , Gilles Salles et al.
Cancer Treatment Reviews, 2015, 41 (9), pp.784-792. ⟨10.1016/j.ctrv.2015.07.003⟩
Journal articles hal-01962569v1

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders

Clémentine Sarkozy , Sophie Kaltenbach , Pierre Faurie , Danielle Canioni , Françoise Berger et al.
Genes, Chromosomes & Cancer, 2017, 56, pp.221-230. ⟨10.1002/gcc.22428⟩
Journal articles hal-01795702v1
Image document

A minimal standardized human bone marrow microphysiological system to assess resident cell behavior during normal and pathological processes

Thibault Voeltzel , Gaëlle Fossard , Michaël Degaud , Kevin Geistlich , Nicolas Gadot et al.
Biomaterials Science, 2022, 10 (2), pp.485-498. ⟨10.1039/d1bm01098k⟩
Journal articles hal-03758030v1

STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA

D. Ghez , C. Fortpied , N. Mounier , P. Carde , A. Perrot et al.
Haematologica, 2016, 101 (5), pp.50
Journal articles hal-03605056v1

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Sydney Dubois , Pierre-Julien Viailly , Elodie Bohers , Philippe Bertrand , Philippe Ruminy et al.
Clinical Cancer Research, 2017, 23 (9), pp.2232-2244. ⟨10.1158/1078-0432.CCR-16-1922⟩
Journal articles hal-01526582v1
Image document

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

J. Lazarovici , P. Dartigues , P. Brice , L. Oberic , I. Gaillard et al.
Haematologica, 2015, 100 (12), pp.1579-1586. ⟨10.3324/haematol.2015.133025⟩
Journal articles inserm-02913989v1

Single- vs double-unit cord blood transplantation for children and young ă adults with acute leukemia or myelodysplastic syndrome

Gerard Michel , Claire Galambrun , Anne Sirvent , Cécile Pochon , Bénédicte Bruno et al.
Blood, 2016, 127 (26), pp.3450-3457. ⟨10.1182/blood-2016-01-694349⟩
Journal articles hal-01482531v1
Image document

Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience

Anne Sophie Alary , Carole Maute , Olivier Kosmider , Pierre Sujobert , Audrey Gauthier et al.
HemaSphere, 2021, 5 (12), pp.e658. ⟨10.1097/hs9.0000000000000658⟩
Journal articles hal-03464576v1

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Alexis Maillard , Rabah Redjoul , Marion Klemencie , Hélène Labussière Wallet , Amandine Le Bourgeois et al.
Blood, 2022, 139 (1), pp.134-137. ⟨10.1182/blood.2021014232⟩
Journal articles hal-03602166v1

Recommandations 2015 du France Intergroupe des Leucémies Myéloïdes Chroniques pour la gestion du risque d'événements cardiovasculaires sous nilotinib au cours de la leucémie myéloïde chronique

Delphine Rea , Shanti Ame , Aude Charbonnier , Valérie Coiteux , Pascale Cony-Makhoul et al.
Bulletin du Cancer, 2016, 103 (2), pp.180-189. ⟨10.1016/j.bulcan.2015.11.008⟩
Journal articles hal-01800007v1

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients: Platinum-containing chemotherapy regimens

F. Tixier , F. Ranchon , A. Iltis , N. Vantard , V. Schwiertz et al.
Hematological Oncology, 2017, 35 (4), pp.584-590. ⟨10.1002/hon.2328⟩
Journal articles hal-01796180v1

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

Laurie H Sehn , Neil Chua , Jiri Mayer , Gregg Dueck , Marek Trněný et al.
Lancet Oncology, 2016, 17 (8), pp.1081-1093. ⟨10.1016/S1470-2045(16)30097-3⟩
Journal articles hal-01800013v1
Image document

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML

Juliette Lambert , Xavier Georges Thomas , Alice Marceau-Renaut , Jean Baptiste Micol , Aline Renneville et al.
Blood Advances, 2021, 5 (23), pp.5258-5268. ⟨10.1182/bloodadvances.2021004322⟩
Journal articles hal-03524576v1
Image document

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Elise Chapiro , Elodie Pramil , M'Boyba Diop , Damien Roos-Weil , Clémentine Dillard et al.
Blood, 2019, 134 (21), pp.1821-1831. ⟨10.1182/blood.2019001187⟩
Journal articles hal-02363995v1

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma

Rémy Gressin , Nicolas Daguindau , Adrian Tempescul , Anne Moreau , Sylvain Carras et al.
Haematologica, 2018, 104 (1), pp.138-146. ⟨10.3324/haematol.2018.191429⟩
Journal articles hal-02265274v1